| # | Drug | Count |
|---|---|---|
| 0 | ALLOPURINOL | 1 |
| 1 | BISOPROLOL FUMARATE | 1 |
| 2 | DAPAGLIFLOZIN | 1 |
| 3 | EPLERENONE | 1 |
| 4 | ORITAVANCIN DIPHOSPHATE | 1 |
| 5 | OXALIPLATIN | 1 |
| 6 | PANTOPRAZOLE | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ORITAVANCIN DIPHOSPHATE | 1 | 0.0034 |
| 1 | EPLERENONE | 1 | 0.0001 |
| 2 | DAPAGLIFLOZIN | 1 | 0.0000 |
| 3 | OXALIPLATIN | 1 | 0.0000 |
| 4 | BISOPROLOL FUMARATE | 1 | 0.0000 |
| 5 | ALLOPURINOL | 1 | 0.0000 |
| 6 | PANTOPRAZOLE | 1 | 0.0000 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Human Immunoglobulin G [EPC] | 1 | 0.0000 |
| 1 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 1 | 0.0000 |
| 2 | Sodium-Glucose Cotransporter 2 Inhibitor [EPC] | 1 | 0.0000 |
| 3 | Aldosterone Antagonist [EPC] | 1 | 0.0000 |
| 4 | Xanthine Oxidase Inhibitor [EPC] | 1 | 0.0000 |
| 5 | Platinum-based Drug [EPC] | 1 | 0.0000 |
| 6 | Tumor Necrosis Factor Blocker [EPC] | 1 | 0.0000 |